跳至主要内容
临床试验/NCT01670617
NCT01670617Unknown不适用

A Stratified, Post-Market Study of DeNovo NT for the Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee

Zimmer Orthobiologics, Inc.34 个研究点 分布在 2 个国家目标入组 90 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
90
试验地点
34
主要终点
Improvement in KOOS scores

研究概览

简要总结

The purpose of this study is to evaluate the long-term relief of pain and return to function for patients receiving DeNovo NT for cartilage lesions in the knee. DeNovo NT is a marketed product and has been used in more than 7,500 patients over the last 7 years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Improvement in KOOS scores

时间窗: Between baseline and 24 months post surgery

Improvement in Knee Injury and Osteoarthritis Outcomes Survey (KOOS) scores

次要结局

  • Incidence and time to reoperation/revision(5 years)
  • Mean IKDC Knee Examination grades(Annually to 5 years post surgery)
  • MRI Evaluation(Preop, 12 Months and 24 Months post surgery)
  • Incidence of adverse events(Annually to 5 years post surgery)
  • X-ray Evaluation(Preop, 12 months and 24 months post surgery)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (34)

Loading locations...

相似试验